72819-0185 Imatinib mesylate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

72819-0185

Brand Name:

Imatinib mesylate

Generic Name:

Imatinib mesylate

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: IMATINIB MESYLATE

Strength: 100.0

Unit: mg/1

Packages:

Code: 72819-0185-09

Description: 90 TABLET in 1 BOTTLE (72819-185-09)

Effective Date: Sept. 1, 2022

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use